1. Agency for Healthcare Research and Quality. Screening for hemoglobinopathies in newborns. Reaffirmation update for US preventive services task force, 2007. Available at: http://www.uspreventiveservicestaskforce.org/BrowseRec/ReferredTopic/230 (accessed 25 August 2017).
2. American College of Obstetricians and Gynecologists. Carrier screening for genetic conditions. Committee Opinion No. 691. Obstet Gynecol. 19 March 2017;129:e41–55. Available at: https://www.acog.org/Resources-And-Publications/Committee-Opinions/Committee-on-Genetics/Carrier-Screening-for-Genetic-Conditions (accessed 31 August 2017).
3. American Society for Hematology. ASH priorities for sickle cell disease and sickle cell trait. Available at: http://www.hematology.org/Research/Recommendations/Sickle-Cell/ (accessed 10 August 2017).
4. Prevention of thalassaemias and other haemoglobin disorders: volume 1: principles [Internet];Angastiniotis,2013
5. Prevention and control of haemoglobinopathies;Angastiniotis;Bull World Health Organ,1995